Scorpion Therapeutics (United States)

Overview

• IndustryPharmaceutical Preparations¹
• HeadquartersBoston, Massachusetts¹
• Websitewww.scorpiontx.com
• Incorporated inDE³
• Business addressOne Winthrop Square, Suite 400, Boston, Ma 02110³
• Legal formCorporation

See how the biggest companies compare on our leaderboards

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

• Executive Officer, DirectorAdam Friedman named Jul 16, 2024⁴
• Executive OfficerAmanda Valentino named Jul 16, 2024⁴
• Executive OfficerAndrew Fedder named Jul 16, 2024⁴
• Executive OfficerBrian Piper named Jul 16, 2024⁴
• Executive OfficerDarrin Stuart named Jul 16, 2024⁴
• Executive OfficerErica Jackson named Jul 16, 2024⁴
• Executive OfficerMark Chao named Jul 16, 2024⁴
• DirectorArjun Goyal named Jul 16, 2024⁴
• DirectorJean-Francois Formela named Jul 16, 2024⁴
• DirectorJeffrey Albers named Jul 16, 2024⁴
• DirectorKeith Flaherty named Jul 16, 2024⁴
• DirectorOleg Nodelman named Jul 16, 2024⁴
• DirectorOtello Stampacchia named Jul 16, 2024⁴
• DirectorSaurabh Saha named Jul 16, 2024⁴
• DirectorShelley Chu named Jul 16, 2024⁴

Timeline

1. 2020Founded Founded¹

Filings

1 filings to the SEC since October 2021: 1 private raises. The latest 1:

1. Jul 16, 2024D EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

1. Jul 1, 2024Raised $125.7 million in a private offering of equity⁴ Form D: $150 million offered in all Form D

SEC filer profile

How Scorpion Therapeutics (United States) is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARScorpion Therapeutics, Inc.²
• CIK0001811858
• Employer ID (EIN)84-5066858²
• Incorporated inDelaware²
• Fiscal year endsDecember 31²
• Industry code (SIC)2834 Pharmaceutical Preparations²
• SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance²
• Business addressOne Winthrop Square, Suite 400, Boston, MA 02110²
• Phone857-326-5077²
• On EDGAR sinceMay 19, 2020²
• Filings3 in all: D (3)²

Links

• Websitewww.scorpiontx.com¹
• WikidataQ104480437
• SEC EDGARCIK 1811858